At this time, posts about Ubicare are rapidly increasing on portals and securities communities. Today, institutional investors have sold a net 5,000 shares. Ubicare is known as a comprehensive IT medical and healthcare solution provider, including EMR.

As of 11:30 AM on the 22nd, Ubicare's stock price is 10,300 KRW, down 4.63% from the previous day, with a trading volume of 1,297,694 shares, which is about 9.57% of the 5-day average trading volume. On May 15th, Ubicare became a market issue with a surge of 22% in stock price amid concerns of a COVID-19 resurgence.

In addition to Ubicare, posts from investors are also rapidly increasing regarding Green Cross LabCell (144510), SMAC (099440), and Daehan Optical Communication (010170).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing